Literature DB >> 33823051

Naturalistic assessment of patterns and predictors of acute headache medication use among women with comorbid migraine and overweight or obesity.

Kathryn E Smith1, J Graham Thomas2, Kristine J Steffen3,4, Richard B Lipton5, Samantha G Farris6, Jelena M Pavlovic5, Dale S Bond2.   

Abstract

Given the potential for obesity to complicate migraine treatment outcomes, there is a need to understand patterns and correlates of acute medication use among individuals with this comorbidity. Experience sampling methodology (ESM) was used to characterize patterns of acute medication use among those with migraine and overweight/obesity and to examine individual and momentary factors related to medication use (both migraine-specific and nonspecific medications). Women with migraine and overweight/obesity (N = 170) seeking behavioral migraine treatment completed questionnaires followed by 28 days of daily ESM headache diaries. Participants used medications to treat 71.9% of attacks, 20% of which were treated with migraine-specific medications. Participants were more likely to use medication in the context of longer and more severe attacks that started earlier in the day. Presence of aura and greater work-related pain interference uniquely related to migraine-specific medication use. Questionnaire-assessed factors were not related to medication use, although older age and higher educational attainment related to more frequent use. A substantial proportion of attacks were left untreated, suggesting unmet treatment needs in this population. Results also suggest that ESM-assessed factors are more salient correlates of medication use compared to questionnaires. Additional investigation of barriers to medication use is needed. © Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ecological momentary assessment; Medication; Migraine; Obesity

Mesh:

Year:  2021        PMID: 33823051      PMCID: PMC8604266          DOI: 10.1093/tbm/ibab027

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  31 in total

1.  Acute migraine medication adherence, migraine disability and patient satisfaction: A naturalistic daily diary study.

Authors:  Elizabeth K Seng; Matthew S Robbins; Robert A Nicholson
Journal:  Cephalalgia       Date:  2016-08-03       Impact factor: 6.292

2.  Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Authors:  Seymour Diamond; Marcelo E Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B Lipton
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

3.  Perceived self-efficacy and headache-related disability.

Authors:  D J French; K A Holroyd; C Pinell; P T Malinoski; F O'Donnell; K R Hill
Journal:  Headache       Date:  2000-09       Impact factor: 5.887

4.  Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.

Authors:  Susan Hutchinson; Richard B Lipton; Jessica Ailani; Michael L Reed; Kristina M Fanning; Aubrey Manack Adams; Dawn C Buse
Journal:  Mayo Clin Proc       Date:  2020-04       Impact factor: 7.616

5.  A six-item short-form survey for measuring headache impact: the HIT-6.

Authors:  M Kosinski; M S Bayliss; J B Bjorner; J E Ware; W H Garber; A Batenhorst; R Cady; C G H Dahlöf; A Dowson; S Tepper
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

6.  Body mass index and episodic headaches: a population-based study.

Authors:  Marcelo E Bigal; Amy Tsang; Elizabeth Loder; Daniel Serrano; Michael L Reed; Richard B Lipton
Journal:  Arch Intern Med       Date:  2007-10-08

Review 7.  Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors:  Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

8.  Race differences in adherence to headache treatment appointments in persons with headache disorders.

Authors:  Bernadette Davantes Heckman; Kenneth A Holroyd; Francis J O'Donnell; Gretchen Tietjen; Christine Utley; Mark Stillman; Gary Ellis
Journal:  J Natl Med Assoc       Date:  2008-02       Impact factor: 1.798

9.  Behavioral Weight Loss Intervention for Migraine: A Randomized Controlled Trial.

Authors:  Dale S Bond; J Graham Thomas; Richard B Lipton; Julie Roth; Jelena M Pavlovic; Lucille Rathier; Kevin C O'Leary; E Whitney Evans; Rena R Wing
Journal:  Obesity (Silver Spring)       Date:  2017-11-27       Impact factor: 5.002

10.  Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.

Authors:  Regina Rendas-Baum; Min Yang; Sepideh F Varon; Lisa M Bloudek; Ronald E DeGryse; Mark Kosinski
Journal:  Health Qual Life Outcomes       Date:  2014-08-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.